Grant: Engage Grants Program
École Polytechnique de Montréal
$25,000.00
Novel delivery systems for dual-activity anti-infective peptides
EF 2012-13
Résumé
Kane biotech is a Canadian biotechnology company and leader in developing new anti-bacterial technologies
for wound care and oral health care. Wounds in the mouth are teeming with bacteria that can sometimes build
up to form a tight colony called a biofilm that resists detergents and antibiotics. Researchers recently made a
breakthrough discovery that the CSP peptide, a small polymer naturally released from bacteria, can be made in
the laboratory and used to interfere with biofilm formation and help kill bacteria. Kane is interested in
expanding the use of CSP anti-bacterial peptides to sinus bone augmentation procedures, but virtually nothing
is known about the fundamental effects of CSP on cells or how to deliver CSP in a way that keeps the peptide
from drifting out of the target area. The main goal of this collaboration is to create completely new delivery
systems for CSP-like peptides, using plastic as a model surface. In this project, CSP peptide and CSP-like
peptides will be made to stick to plastics in a way that retains their activity. The peptide-coated plastics will be
exposed to bacteria to show that they are still effective in preventing biofilm formation. The peptide-coated
plastics will also be exposed to stem cells, a cell type normally found in wounds, to show that the coated
surfaces still permit the cells to carry out their normal functions. These experiments will show whether CSP
peptide technology can be used in a more economical way as a coating instead of applying as a wasteful liquid.
This project will generate a new way to keep CSP peptides at a target area, and will help Kane biotech continue
to be a leader in producing new anti-biofilm technologies. Results from this study could eventually lead to new
delivery systems towards better treatments for subjects with infections that are unable to respond to antibiotics.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
430448-2012
Name nom
Hoemann, Caroline
Department département
Génie chimique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Novel delivery systems for dual-activity anti-infective peptides
Keyword
NSERC
Application summary
Kane biotech is a Canadian biotechnology company and leader in developing new anti-bacterial technologies
for wound care and oral health care. Wounds in the mouth are teeming with bacteria that can sometimes build
up to form a tight colony called a biofilm that resists detergents and antibiotics. Researchers recently made a
breakthrough discovery that the CSP peptide, a small polymer naturally released from bacteria, can be made in
the laboratory and used to interfere with biofilm formation and help kill bacteria. Kane is interested in
expanding the use of CSP anti-bacterial peptides to sinus bone augmentation procedures, but virtually nothing
is known about the fundamental effects of CSP on cells or how to deliver CSP in a way that keeps the peptide
from drifting out of the target area. The main goal of this collaboration is to create completely new delivery
systems for CSP-like peptides, using plastic as a model surface. In this project, CSP peptide and CSP-like
peptides will be made to stick to plastics in a way that retains their activity. The peptide-coated plastics will be
exposed to bacteria to show that they are still effective in preventing biofilm formation. The peptide-coated
plastics will also be exposed to stem cells, a cell type normally found in wounds, to show that the coated
surfaces still permit the cells to carry out their normal functions. These experiments will show whether CSP
peptide technology can be used in a more economical way as a coating instead of applying as a wasteful liquid.
This project will generate a new way to keep CSP peptides at a target area, and will help Kane biotech continue
to be a leader in producing new anti-biofilm technologies. Results from this study could eventually lead to new
delivery systems towards better treatments for subjects with infections that are unable to respond to antibiotics.